Cleanroom Workforce Qualification Recovery Authority — Cell Therapy

The mandate

The new facility records learning completion centrally, but gowning, aseptic manipulation, line clearance and intervention authorisations remain in suite-specific matrices. Contractors and transferred staff inherit broad curricula without proving local equipment practice.

The nine-month assignment begins within ten days and covers deployment containment, qualification reconstruction, three production campaigns and permanent-leader induction. A procedure revision, equipment change, contamination event, extended absence, failed observation, suite transfer or contractor substitution becomes a governed qualification event. Six weeks are reserved for handover; no extension will cover routine training administration.

Exit requires a task and prerequisite dictionary, reconciled person-authorisation matrix, qualified instructors and assessors, controlled observed practice, expiry and requalification rules, roster checks, deviation feedback and three campaigns without unqualified deployment. The successor must adjudicate an unseen suite transfer after a prolonged absence and defend readiness to Quality before accepting authority.

The interim may remove people from cleanroom rosters, suspend qualification routes lacking evidence, require supervised practice, change temporary training leads, set requalification thresholds and control SAR 52 million of authorised remediation. Quality retains batch, deviation and GMP decisions; manufacturing leaders deploy staff; authorised assessors sign competence; Occupational Health retains protected fitness decisions.

Process design, batch disposition, deviation investigation, medical decisions, employment action, certification of facilities and regulator negotiation are outside scope. The leader may restrict workforce deployment but cannot determine product quality or blame. Production urgency will not justify retrospective observation records, expired prerequisites or equivalence based solely on prior employer certificates.

Why this seat is open

Training completion was mistaken for current authorisation to perform specific aseptic work, and the investigation exposed weak links among procedures, observed practice and rosters. Temporary authority must protect imminent campaigns, rebuild task-level evidence and leave a permanent owner capable of governing unfamiliar suite and equipment changes.

What you will own

• Map gowning, material transfer, aseptic manipulation, intervention, clearance and monitoring tasks to evidence-based prerequisites and expiry conditions.
• Reconcile employees, contractors, transfers, trainers and assessors across learning records, suite authorisation matrices and live deployment rosters.
• Define knowledge, simulation, supervised batches, observed performance, pass, expiry and requalification evidence.
• Govern procedure, equipment, suite, absence, deviation and environmental-event triggers for renewed qualification.
• Establish assessor calibration, independence, sampling, borderline-case review and durable evidence-retention controls across manufacturing suites.
• Command three campaigns plus a contamination event, contractor substitution and critical-procedure revision.
• Transfer qualification authority after the successor resolves an unseen suite-transfer and skill-decay case.

Candidate qualifications

• Held GMP workforce-qualification authority in cell therapy, sterile biologics or advanced aseptic manufacturing.
• Reconciled curricula, task matrices, observed performance, assessor evidence and deployment rosters at operator level.
• Recovered qualification controls after contamination, media-fill or inspection findings under production pressure.
• Calibrated instructors and assessors across suites, equipment, procedures and employee or contractor populations.
• Preserved boundaries among workforce qualification, Quality disposition, deviation investigation, health and employment action.
• Handed recovered task authorisation to permanent leadership through repeated live clinical manufacturing campaigns and unfamiliar regulated procedure changes.